ovarian neoplasm
Information
- Disease name
- ovarian neoplasm
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05257408 | Active, not recruiting | Phase 3 | Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer | June 29, 2022 | June 2025 |
| NCT03667716 | Active, not recruiting | Phase 1 | COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. | September 6, 2018 | May 31, 2024 |
| NCT00001898 | Completed | Microarray Analysis for Human Genetic Disease | June 29, 1999 | May 20, 2008 | |
| NCT00001938 | Completed | A Pilot Study of a Protein Profile Test in Ovarian Cancer Patients in Remission to See if Protein Changes Can Predict Relapse (be Predictive of Cancer Relapse) | April 24, 2000 | March 10, 2020 | |
| NCT00034281 | Completed | Phase 1 | Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2 | June 2002 | September 2003 |
| NCT00069901 | Completed | Phase 2 | Phase II CT-2103/Carboplatin in Ovarian Cancer | February 2003 | September 2006 |
| NCT00248248 | Completed | Phase 2 | DOXIL for Consolidation Therapy in Ovarian Cancer. | October 2005 | October 2011 |
| NCT00436215 | Completed | Phase 2 | Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer | December 12, 2006 | September 27, 2014 |
| NCT00494442 | Completed | Phase 2 | Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Ovarian Cancer | June 11, 2007 | July 20, 2017 |
| NCT01139957 | Completed | Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer | June 7, 2010 | April 10, 2020 | |
| NCT05751629 | Completed | Phase 2 | Study to Evaluate the Safety and Efficacy of TSR-042, Bevacizumab, and Niraparib in Participants With Recurrent Ovarian Cancer | November 15, 2018 | April 1, 2022 |
| NCT05512676 | Completed | Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed Ovarian Cancer Patients Allergic to Platinum | March 7, 2016 | August 1, 2022 | |
| NCT01608009 | Completed | Phase 1 | [18F]Fluciclatide-PET, Pazopanib and Paclitaxel in Ovarian Cancer | July 2012 | April 2016 |
| NCT01821833 | Completed | N/A | Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel | May 24, 2016 | August 3, 2022 |
| NCT01896778 | Completed | N/A | Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer | October 4, 2013 | February 23, 2018 |
| NCT01929720 | Completed | N/A | Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors | August 2011 | September 2014 |
| NCT02520115 | Completed | Phase 1 | Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer | August 2015 | November 2018 |
| NCT00001426 | Completed | Phase 2 | A Multi-Institutional Phase II Study of Cyclophosphamide, Paclitaxel, Cisplatin With G-CSF for Patients With Newly Diagnosed Advanced Stage Ovarian Cancer | February 3, 1995 | November 7, 2013 |
| NCT04898842 | Completed | N/A | Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet | March 2, 2021 | November 2, 2022 |
| NCT04573933 | Completed | Survival Data and Characteristics of Finisterian Patients Treated With PARP Inhibitors for Ovarian Cancer Between 2014 and 2019. | June 29, 2020 | August 29, 2020 | |
| NCT03012620 | Completed | Phase 2 | Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types | July 5, 2017 | December 14, 2023 |
| NCT03379376 | Completed | N/A | EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery | April 5, 2018 | November 2, 2018 |
| NCT03562897 | Completed | Phase 2 | Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer | October 25, 2018 | June 15, 2022 |
| NCT03681405 | Completed | N/A | Supportive Programs for Supporting Optimal Recovery in Participants Undergoing Gynecological Surgery | December 7, 2018 | April 9, 2020 |
| NCT05960630 | Recruiting | N/A | MIRRORS-RCT Pilot: Role of Robotic Interval Cytoreductive Surgery for Advanced Ovarian Cancer | October 2, 2023 | December 31, 2024 |
| NCT02732860 | Recruiting | Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host | December 2015 | January 4, 2025 | |
| NCT04561362 | Recruiting | Phase 1/Phase 2 | Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies | July 17, 2020 | December 2025 |
| NCT04906187 | Recruiting | N/A | Impact of Specific Monitoring of Intraoperative Analgesia Under General Anesthesia on Chronic Pain After Ovarian Cancer Surgery | May 31, 2021 | August 25, 2024 |
| NCT05059782 | Recruiting | N/A | Efficacy and Safety of Involving Field Radiotherapy in the Oligo-lesions(Metastasis/Recurrent/Refractory) of Ovarian Cancer | October 10, 2021 | September 1, 2024 |
| NCT05752448 | Recruiting | N/A | Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O) | October 1, 2023 | April 15, 2027 |
| NCT01374685 | Terminated | Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans | June 7, 2011 | January 7, 2016 | |
| NCT00001827 | Terminated | Phase 2 | p53 Vaccine for Ovarian Cancer | July 26, 1999 | January 25, 2013 |
| NCT02470585 | Terminated | Phase 3 | Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | June 29, 2015 | October 5, 2023 |
| NCT04402333 | Unknown status | Minimally Invasive Robotic Surgery, Role in Optimal Debulking Ovarian Cancer, Recovery & Survival | June 26, 2020 | October 3, 2021 | |
| NCT03000192 | Unknown status | HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life | August 2016 | September 2021 | |
| NCT03006939 | Unknown status | Fluid Balance During Surgery for Ovarian Cancer | December 2016 | December 2022 | |
| NCT01477788 | Withdrawn | Prediction of Ovarian Malignancy in the Presence of Sonographic Pelvic Mass | May 2011 | May 2011 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100615